Loading…
Based on limited metadata, this FDA Warning Letter issued to Boothwyn Pharmacy LLC on July 25, 2018, involves a pharmacy operation and an unspecified product category classified as "Other." Without access to the full letter text or a detailed subject line, the specific nature of the violations cannot be determined from the available information. The issuing office is also not identified in the metadata provided, limiting clarity on the precise regulatory scope of the enforcement action.